Eliminate Financial Risk and Improve Control
In an era where top-line growth is slowing due to shorter product lifecycles, growing buyer sophistication, and enhanced regulatory scrutiny, Medical Device finance organizations are under increasing pressure to reign in lost revenue and "get the numbers right." Increasing margins and improving visibility and control over the revenue life cycle are vital in turning this top-line problem into bottom-line success.
Model N's unique combination of integrated transactional Revenue Management solutions, deep domain expertise, and best practices are helping manufacturers create a foundation for the risk mitigation and revenue maximization while delivering the insights needed by marketing, sales, and finance organizations to stay ahead of the curve in a highly competitive marketplace.
- (650) 610-4600
- Request Information
With regulatory changes imposed by the Deficit Reduction Act looming, Procter & Gamble and Model N worked together to successfully implement the Government Pricing application within an aggressive nine-month timeframe. No matter what obstacle or challenge we presented, Model N responded with a workable solution.
Ron Brandt, Director of Contracting
Procter & Gamble Pharma